BALLOON Study

Cross-source consensus on BALLOON Study from 1 sources and 4 claims.

1 sources · 4 claims

Dosage & preparation

The trial plans to recruit 542 infants and randomise them equally to Bactek or matching placebo. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol
Treatment starts at term-equivalent age or earlier discharge and continues once daily until 1 year corrected age. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol
The BALLOON study is a UK multicentre, double-blind, randomised, parallel-group, placebo-controlled trial of Bactek in very or extremely preterm infants. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol
The study includes formal follow-up at 3, 6, 9 and 12 months and safety follow-up to 13 months corrected age. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol